Figure 1.

Drug repurposing workflow. A multilayer drug-protein-disease heterogeneous network was constructed on the basis of public databases. Then, a random walk method was implemented to identify potential drug-disease relationships. Novel candidates were validated with in vitro and in vivo experimental tests.